Brokers Set Expectations for Clorox’s Q3 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX) – Equities research analysts at Zacks Research lowered their Q3 2027 earnings estimates for shares of Clorox in a report released on Friday, October 23rd. Zacks Research analyst Team now forecasts that the company will post earnings of $1.56 per share for the quarter, down from their prior estimate of $1.62. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.66 per share. Zacks Research also issued estimates for Clorox’s Q4 2027 earnings at $1.77 EPS.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The company had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.91 billion. During the same period last year, the company posted $2.87 EPS. Clorox’s revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS.

Several other equities analysts have also issued reports on the stock. BNP Paribas Exane lowered their target price on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a report on Monday, July 20th. Citigroup cut their price target on Clorox from $97.00 to $90.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 14th. Morgan Stanley reduced their price objective on Clorox from $97.00 to $87.00 and set an “equal weight” rating for the company in a research report on Thursday, October 15th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $95.00 price objective on shares of Clorox in a research note on Monday, October 19th. Finally, Barclays dropped their target price on Clorox from $84.00 to $80.00 and set an “underweight” rating on the stock in a report on Friday, October 16th. Twelve analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $93.57.

Clorox Price Performance

Shares of NYSE CLX opened at $86.78 on Tuesday. Clorox has a fifty-two week low of $79.12 and a fifty-two week high of $128.90. The company has a 50 day simple moving average of $90.49 and a two-hundred day simple moving average of $100.42. The company has a market capitalization of $10.50 billion, a price-to-earnings ratio of 18.00, a P/E/G ratio of 2.89 and a beta of 0.59. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 5.8%. The ex-dividend date is Wednesday, October 28th. Clorox’s dividend payout ratio (DPR) is currently 103.73%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of CLX. Kestra Private Wealth Services LLC grew its holdings in shares of Clorox by 1.8% in the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after buying an additional 104 shares during the period. Geneos Wealth Management Inc. increased its position in shares of Clorox by 9.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company’s stock valued at $145,000 after buying an additional 119 shares in the last quarter. Elevation Wealth Partners LLC raised its stake in Clorox by 32.3% during the 3rd quarter. Elevation Wealth Partners LLC now owns 565 shares of the company’s stock worth $46,000 after buying an additional 138 shares during the period. Root Financial Partners LLC raised its stake in Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after buying an additional 145 shares during the period. Finally, Eastern Bank lifted its holdings in Clorox by 3.1% during the third quarter. Eastern Bank now owns 5,052 shares of the company’s stock worth $409,000 after acquiring an additional 150 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Neutral Sentiment: Clorox expects modest organic sales growth in fiscal 2027, and its nearly 6% dividend yield may attract income-focused investors. However, the company is also absorbing integration costs from a recent acquisition, while debt has doubled to approximately $5 billion. Should You Forget Clorox Stock Near a 52-Week Low?
• Negative Sentiment: Zacks Research cut its fiscal third-quarter 2027 EPS forecast to $1.56 from $1.62 and its fourth-quarter forecast to $1.77 from $1.82. The firm maintains a “Hold” rating, adding pressure to expectations ahead of Clorox’s results. Clorox Stock Sees Q1 Earnings Estimate Cut at Zacks Research
• Negative Sentiment: UBS expects fiscal first-quarter organic sales growth to remain pressured and costs to weigh on earnings, suggesting limited near-term operating momentum. Clorox’s Fiscal Q1 Organic Sales Growth to Stay Pressured, With Costs Impacting Earnings, UBS Says
• Negative Sentiment: Recent coverage points to a 5% decline in net sales, with profits falling even faster. Macroeconomic pressure, acquisition-related expenses and elevated leverage are clouding the investment case. Macroeconomic Headwinds are Hitting Clorox From All Sides
• Negative Sentiment: Zacks also says Clorox lacks the favorable combination of factors that typically supports an earnings beat, increasing concern around the upcoming report. Full-year consensus currently stands at $5.66 EPS. Clorox Earnings Expected to Grow: Should You Buy?

Clorox Company Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.